Implant Phenotype Modification Via GBR and ADM
Phenotype Modification Via Guided Bone Regeneration and Acellular Dermal Matrix Simultaneous to Delayed Implant Placement: A Double Arm Randomized Controlled Clinical Trial.
University of Michigan
40 participants
Jun 1, 2025
INTERVENTIONAL
Conditions
Summary
Single implant sites with bone loss can often be managed by bone grafting alone. The purpose of this study is to determine whether putting a soft tissue graft substitute over the bone graft will provide an increased benefit for improving the health, appearance, and stability of the bone and gums surrounding the implant.
Eligibility
Inclusion Criteria7
- Age ≥ 18 years.
- Subjects with a physical status of systemically healthy or suffering from mild to moderate, but well-controlled disease; American Society of Anesthesiology (ASA) I or II.
- Subjects must have one edentulous region, with at least 3 months of healing post-extraction, in the esthetic zone of the maxilla or the premolar and canine region of the mandible. This region includes the maxillary premolars, canines, and incisors.
- Subjects must have a full mouth plaque and bleeding score of less than or equal to 20%, measured at four sites per tooth.
- The patients should have a thin periodontal phenotype; bucco-lingual ridge thickness greater than 6mm.
- Seibert class I deficiency (Seibert, 1983)
- Patients willing to sign the informed consent.
Exclusion Criteria7
- Presence of uncontrolled and/or untreated periodontal disease.
- Patients currently smoking cigarettes, cannabis, and electronic cigarettes.
- Subjects taking medications known to impact bone metabolism or have the capacity to affect wound healing. These drugs include bisphosphonates, corticosteroids, parathyroid hormone, RANKL inhibitors, past exposure to head and neck radiation, chemotherapy within the last 12 months, among others.
- Subjects with systemic diseases that impact bone metabolism and wound healing. Namely, osteoporosis, osteopenia, hyperparathyroidism, Paget's disease.
- Allergy to the graft materials.
- Pregnant subjects or individuals who self-report as attempting to become pregnant.
- Patient's unwilling to sign the informed consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will have a dental implant placed at a toothless site
Participants will receive guided bone regeneration at a toothless site with bone substitute and a collagen membrane.
Participants will receive guided bone regeneration at a toothless site with bone substitute and an acellular dermal matrix.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07082244